Literature DB >> 14293000

IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS.

A S YOUMANS, G P YOUMANS.   

Abstract

Youmans, Anne S. (Northwestern University Medical School, Chicago, Ill.), and Guy P. Youmans. Immunogenic activity of a ribosomal fraction obtained from Mycobacterium tuberculosis. J. Bacteriol. 89:1291-1298. 1965.-The highly immunogenic particulate fraction obtained from mechanically ruptured cells of the H37Ra strain of Mycobacterium tuberculosis was suspended and centrifuged at 20,360 x g. The supernatant liquid from this centrifugation was centrifuged at 56,550 x g to remove the larger particles, and the supernatant liquid from this was centrifuged at 144,000 x g to obtain a ribosomal fraction. The sediments from the first two centrifugations were highly immunogenic, but the ribosomal fraction showed only slight capacity to immunize mice. However, when the ribosomal fraction was mixed with Freund's incomplete adjuvant, the immunogenic activity was equivalent to the particulate fraction from which it was prepared. To test the hypothesis that some membranous substance in the particulate fraction was acting as an adjuvant for the smaller particles in the ribosomal fraction, portions of the particulate fraction were treated separately with each of the membrane-disrupting agents, sodium deoxycholate, sodium lauryl sulfate, and 1 m sodium chloride. The treated materials were then centrifuged at 144,000 x g, and the sediments were tested for immunogenicity both with and without the addition of Freund's incomplete adjuvant. Without the adjuvant, the immunizing activities were very weak or absent; with the adjuvant, they were equivalent to that of the particulate fraction from which they were prepared. Other factors which have been found to damage or destroy membranes, such as freezing and thawing, and heat, also significantly decreased the immunogenic activity of the particulate fraction unless it was incorporated into Freund's incomplete adjuvant. The larger particles which sedimented at 56,550 x g were also treated with sodium lauryl sulfate and sodium chloride. Again, immunogenicity was greatly reduced but was fully restored by use of Freund's incomplete adjuvant. The data suggest, then, that the immunizing component of the particulate fraction is a substance (ribosomal?) which sediments at 144,000 x g, but for maximal immunizing activity a labile, possibly membranous, moiety of the mycobacterial cell, which has the properties of an adjuvant, is required.

Entities:  

Keywords:  BILE ACIDS AND SALTS; CENTRIFUGATION; EXPERIMENTAL LAB STUDY; FREEZING; FREUND'S ADJUVANT; HEAT; MICE; MYCOBACTERIUM TUBERCULOSIS; PHARMACOLOGY; RIBOSOMES; RNA, BACTERIAL; SODIUM CHLORIDE; SURFACE-ACTIVE AGENTS

Mesh:

Substances:

Year:  1965        PMID: 14293000      PMCID: PMC277642          DOI: 10.1128/jb.89.5.1291-1298.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  The preparation and some properties of a low molecular weight ribonucleic acid from baker's yeast.

Authors:  R MONIER; M L STEPHENSON; P C ZAMECNIK
Journal:  Biochim Biophys Acta       Date:  1960-09-09

2.  Studies on mitochondria. VII. The relationship between the control of structure and the dinitrophenol stimulation of adenosinetriphosphatase in liver mitochondria.

Authors:  J C KALTENBACH; J W HARMAN
Journal:  Exp Cell Res       Date:  1955-06       Impact factor: 3.905

3.  Phosphorylation coupled to oxidation in bacterial extracts.

Authors:  A F BRODIE; C T GRAY
Journal:  J Biol Chem       Date:  1956-04       Impact factor: 5.157

4.  Bacterial particles in oxidative phosphorylation.

Authors:  A F BRODIE; C T GRAY
Journal:  Science       Date:  1957-03-22       Impact factor: 47.728

5.  Dissociation of macromolecular ribonucleoprotein of yeast.

Authors:  F C CHAO
Journal:  Arch Biochem Biophys       Date:  1957-08       Impact factor: 4.013

6.  The preparation and characterization of ribonucleic acids from yeast.

Authors:  A M CRESTFIELD; K C SMITH; F W ALLEN
Journal:  J Biol Chem       Date:  1955-09       Impact factor: 5.157

7.  FURTHER STUDIES ON A LABILE IMMUNOGENIC PARTICULATE SUBSTANCE ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1964-02       Impact factor: 3.490

8.  EFFECT OF MITOCHONDRIAL STABILIZERS ON THE IMMUNOGENICITY OF THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1964-06       Impact factor: 3.490

9.  NATURE OF THE LABILE IMMUNOGENIC SUBSTANCE IN THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1964-10       Impact factor: 3.490

View more
  77 in total

Review 1.  Ribosomal immunotherapy for recurrent respiratory tract infections in children.

Authors:  Marie C Béné; Gilbert C Faure
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  Evaluation of a ribosomal vaccine against pertussis.

Authors:  L H Field; C D Parker; C R Manclark; L J Berry
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

Review 3.  Fungal ribosomal vaccines. I. Histoplasma and Candida vaccines.

Authors:  E Segal
Journal:  Mycopathologia       Date:  1989-01       Impact factor: 2.574

4.  T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.

Authors:  J F van den Bosch; I Y Kanis; A C Antonissen; W A Buurman; C P van Boven
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

5.  Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG.

Authors:  P Minden; P J Kelleher; J H Freed; L D Nielsen; P J Brennan; L McPheron; J K McClatchy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

6.  Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.

Authors:  G Bachrach; M Banai; S Bardenstein; G Hoida; A Genizi; H Bercovier
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Resolution and identification of ribosomes from mycobacteria.

Authors:  L Trnka; E Wiegeshaus; D W Smith
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

8.  Cell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

9.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

10.  Delayed dermal hypersensitivity in rhesus monkeys (Macaca mulatta) immunized against Plasmodium knowlesi.

Authors:  E J Cabrera; C A Speer; R H Schenkel; M L Barr; P H Silverman
Journal:  Z Parasitenkd       Date:  1976-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.